MAPT and Alzheimer disease: DNA methylation changes are present in AD-related genes; some of these genes are hypermethylated (MTHFR, Neprilysin, MAPT, APOE, SORB3), while others—including those required for the production of the Aβ peptide—have been found to be hypomethylated (APP, BACE, PSEN1, PP2A, S100A2, CREB5) [336,337].